Perbedaan Charlie Hospital Semarang Tbk. dan Zyrexindo Mandiri Buana Tbk.: Charlie Hospital Semarang Tbk. diperdagangkan di Rp270 (kapitalisasi pasar 742 M, volume 24 jam 29,45 jt), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp129 (kapitalisasi pasar 173,33 M, volume 24 jam 1,04 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 4,3× kapitalisasi pasar Zyrexindo Mandiri Buana Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (29,45 jt vs 1,04 jt). Mana yang lebih baik tergantung tujuan investasimu.
| RSCH | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 742 M | 173,33 M |
Volume | 29,45 jt | 1,04 jt |
Lot | 294,49 rb | 10,41 rb |
Perputaran | 8,14 M | 134,49 jt |
Harga Rata-rata | 276,35 | 129,19 |
Nilai Transaksi | 8,14 M | 134,49 jt |
Harga Ekuilibrium Indikatif | 270 | 129 |
Volume Ekuilibrium Indikatif | 103 | 15 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →